Discontinued — last reported Q4 '25
Contract Sales & Medical Solutions — Segment profit
IQVIA Contract Sales & Medical Solutions — Segment profit decreased by 7.7% to $12.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $13.00M to $12.00M. Over 4 years (FY 2021 to FY 2025), Contract Sales & Medical Solutions — Segment profit shows a downward trend with a -10.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase signals improved operational performance and profitability, while a decrease indicates margin pressure or rising costs.
Detailed definition
This is the primary measure of the segment's operational performance, calculated as revenue minus direct costs and admin...
Peer comparison
Standard segment operating income metric used to compare performance across business units in diversified firms.
iqv_segment_contract_sales_medical_solutions_segment_profitHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.00M | $20.00M | $15.00M | $12.00M | $13.00M | $8.00M | $9.00M | $13.00M | $12.00M | $12.00M | $12.00M | $13.00M | $9.00M | $12.00M | $13.00M | $11.00M | $12.00M | $13.00M | $12.00M |
| QoQ Change | — | +0.0% | -25.0% | -20.0% | +8.3% | -38.5% | +12.5% | +44.4% | -7.7% | +0.0% | +0.0% | +8.3% | -30.8% | +33.3% | +8.3% | -15.4% | +9.1% | +8.3% | -7.7% |
| YoY Change | — | — | — | — | -35.0% | -60.0% | -40.0% | +8.3% | -7.7% | +50.0% | +33.3% | +0.0% | -25.0% | +0.0% | +8.3% | -15.4% | +33.3% | +8.3% | -7.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IQVIA's contract sales & medical solutions — segment profit?
- IQVIA (IQV) reported contract sales & medical solutions — segment profit of $12.00M in Q4 2025.
- How has IQVIA's contract sales & medical solutions — segment profit changed year-over-year?
- IQVIA's contract sales & medical solutions — segment profit decreased by 7.7% year-over-year, from $13.00M to $12.00M.
- What is the long-term trend for IQVIA's contract sales & medical solutions — segment profit?
- Over 4 years (2021 to 2025), IQVIA's contract sales & medical solutions — segment profit has grown at a -10.6% compound annual growth rate (CAGR), from $75.00M to $48.00M.
- What does contract sales & medical solutions — segment profit mean?
- The operating profit generated by the segment after accounting for direct and indirect costs.